Genesco to Report First Quarter Fiscal 2025 Results and Hold Conference Call on May 31, 2024
Genesco Inc. (NYSE:GCO) today announced that the Company will report results for the first quarter fiscal 2025 on May 31, 2024, before the market opens, and hold its quarterly earnings conference call at 7:30 a.m.
Genesco Inc. Launches Executive Severance Plan
Insider Stock Buying Reaches US$884.6k On Genesco
JOHNSTON & MURPHY UNVEILS NEW LOOK WITH LATEST BRAND CAMPAIGN
Today, American premium lifestyle brand, Johnston & Murphy reveals its new image campaign titled, 'Not Your Dad's Shoe Company.' Designed to reshape...
Q4 Earnings Highlights: Nike (NYSE:NKE) Vs The Rest Of The Footwear Stocks
Genesco Full Year 2024 Earnings: US$2.10 Loss per Share (Vs US$5.80 Profit in FY 2023)
Seaport Global Sticks to Its Hold Rating for Genesco (GCO)
Analysts Have Conflicting Sentiments on These Consumer Cyclical Companies: Genesco (GCO) and Karat Packaging Inc (KRT)
Earnings Call: Genesco Outlines Strategies Amid Fiscal Challenges
Further Weakness as Genesco (NYSE:GCO) Drops 17% This Week, Taking Three-year Losses to 47%
Many investors define successful investing as beating the market average over the long term. But in any portfolio, there are likely to be some stocks that fall short of that benchmark. Unfortunately
Genesco Inc. (NYSE:GCO) Q4 2024 Earnings Call Transcript
Genesco Shares Decline Following Q4 Earnings Report
Genesco (GCO) shares were down more than 11% in recent Friday trading following the company's fiscal Q4 earnings report. The company reported fiscal Q4 adjusted earnings of $2.59 per share, down from
Earnings Call Summary | Genesco(GCO.US) Q4 2024 Earnings Conference
The following is a summary of the Genesco Inc. (GCO) Q4 2024 Earnings Call Transcript:Financial Performance:Genesco reported Q4 revenue of $739 million, a 2% rise mainly driven by all divisions except
Why Branded Footwear Retailer Genesco's Shares Are Tumbling Today
Genesco Inc (NYSE:GCO) shares are plummeting after reporting fourth-quarter FY24 sales growth of 2% year-on-year to $738.95 million, beating the analyst consensus estimate of $705.66 million.Excluding
Top Premarket Decliners
Amylyx Pharmaceuticals (AMLX) shares slumped 80% Friday premarket after the company said its phase 3 study of a potential treatment of amyotrophic lateral sclerosis failed to meet its primary endpoint
Genesco Inc (GCO) Reports Mixed Fiscal 2024 Results Amid Challenging Retail Environment
Express News | Genesco Shares Are Trading Lower After the Company's Reported a Q4 EPS Miss and Issued Weak FY25 Guidance
Genesco Issues Soft Fiscal-Year Profit Guidance After Soft Holiday Demand For Shoes
By Will Feuer Genesco issued soft adjusted earnings guidance for its current fiscal year after higher costs, winter storms and soft demand for footwear weighed on the retailer in the holiday quarter.
Genesco (NYSE:GCO) Beats Q4 Sales Targets
Earnings Flash (GCO) GENESCO Posts Q4 Revenue $739M
06:55 AM EST, 03/08/2024 (MT Newswires) -- Earnings Flash (GCO) GENESCO Posts Q4 Revenue $739M